Tuesday, 25 Apr 2023 | Funding Deadline
The NIHR is inviting research proposals that seek to develop the critical underlying infrastructure to accelerate progress in and learning from MND clinical trials. This will build on existing initiatives, networks and collaborations that capitalise on recent progress in drug development, to improve trial design and participation, validate new patient relevant outcomes and validate identified clinical biomarkers that are known to correlate to a clinical endpoint.
NIHR is interested in funding studies that use innovative trial designs that have the potential to increase patient participation in clinical studies. This could be through the use of stratification, predictive modelling, and/or the use of novel study designs, such as platform trials and n-of-1 studies. Applicants should also consider the efficiency of studies to reduce the burden on participants, such as the use of remote monitoring or bio sampling.
Several NIHR programmes will participate in this call. At present, the Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications.
Deadline for proposals: 25 April 2023
Find out more here